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Introduction 
Engineered Nanomaterials (NMs) (with at least one dimension 
between 1-100 nm) are being developed and exploited because of 
their unusual and interesting properties exhibited at the nano-scale, 
compared to larger materials [1,2]. These properties have led to their 
incorporation into over 1300 consumer products [3]. Their widespread 
utilisation in everyday products suggests that exposure to humans and 
the environment is ever increasing, and since air pollution particles 
of similar sizes are known to induce morbidity and mortality [4], 
concerns about the environmental and human health impacts of NMs 
have been raised [1].
The lungs and the gastrointestinal tract are in constant contact 
with the external environment-hence it is not surprising to find these 
systems being primary exposure sites for NMs [5,6]. Research indicates 
that NMs administered via ingestion, inhalation or intravenous 
injection rapidly reach secondary tissues, especially the liver [7-9]. As 
a secondary exposure site, the liver has huge importance, as it has been 
shown to accumulate NMs at high volumes (>90%), compared to other 
organs [9,10], and alongside the kidneys, may be responsible for the 
clearance of NMs from the blood [7-9]. The prominent advances in 
the field of nanomedicine have resulted in an increase in direct entry 
of NMs into the circulatory system. The presence of nanomaterials in 
the blood allows distribution to a wide range of target organs, including 
the liver.
The liver is the metabolic centre of the body [9]. It has a crucial 
role in metabolic homeostasis, as it is responsible for the storage, 
synthesis, metabolism and re-distribution of carbohydrates, fats and 
vitamins. It also produces large numbers of serum proteins and an 
array of enzymes, cytokines, and various important serum proteins 
such as complement components and acute phase proteins, crucial in 
the mammalian innate immune system [11]. 
Neutrophils also referred to as Polymorphonuclear leukocytes 
(PMNs) are the most abundant of all white blood cells, comprising of 
up to 70% of all leukocytes [12]. Neutrophils are the front line effectors 
of the innate immune system: after differentiation, these cells circulate 
in the bloodstream, before migrating into tissues [13]. These cells are 
solely responsible for surveillance and constituting the first line of 
defence against foreign antigens [14]. Hence, it is not surprising that 
in the event of an inflammatory response, there is usually an increase 
in PMN numbers, mobility, tissue influx and phagocytic ability 
[12]. Neutrophils are the most active phagocytic cells in the host’s 
immune system arsenal. They are capable of ingestion of antigens into 
specialised phagosomes, and producing a wide array of cytotoxic agents 
to eliminate the foreign particle [15]. The role of PMNs in disposal 
of NMs is not yet fully understood, however, it has been shown that 
nanomaterial exposure in the lungs results in a large increase in PMN 
numbers in the tissue [4]. 
Here, we investigated the leukocyte influx into the liver, following 
IV exposure of mice to a panel of NMs including Ag, ZnO, TiO2 and 
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Abstract
Background and methods: Following exposure via a number of routes (inhalation, ingestion or injection), some 
Nanomaterials (NMs) translocate to secondary tissues, prominently the liver. This study investigated the effects of an 
array of NMs, varying in their physicochemical characteristics, consisting of two types of Zinc Oxide (ZnO), two Multi-
walled Carbon Nanotubes (MWCNT), one silver (Ag) and one titanium dioxide (TiO2) on the liver, following Intravenous 
(IV) exposure of C57/BL6 mice. The animals were exposed to either a single dose of NM (128 µg/ml–100 µl) or three 
doses of (64 µg/ml–100 µl), every 24 hr. Animals were dissected 6, 24, 48 and 72 hr after the single IV injection, or 72 
hr after the triple injection regime. 
Results and conclusions: A Myeloperoxidase (MPO) assay was utilised to quantify neutrophil influx into the 
tissue. However, as MPO is also found in other granulocytes in smaller quantities, the neutrophils in the liver tissue were 
also labelled, using a specific neutrophil cell surface marker (Ly-6B.2). A wide array of NMs (including ZnO, Ag, TiO2 
and MWCNT) induced a neutrophil influx into the liver, as early as 6 hr post IV exposure. However, the neutrophils were 
only involved in the initial phases of the immune response against the NMs, as the leukocyte numbers had returned to 
control levels after 48 hr. Finally, analysis of mRNA expression in mice livers showed alterations in levels of C3, IL6, 
IL10, CXCL2 and ICAM-1.
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MWCNT. These NMs, as part of the FP7 ENPRA (Risk assessment of 
engineered nanoparticles) consortium, were chosen as they represent 
NMs in a variety of products, and therefore, very real prospect of 
the materials reaching the blood stream, hence translocating to the 
liver. In order to confirm whether these nanomaterials could induce 
a neutrophilic response in the liver, and to identify whether this 
response was short-lived or more prolonged, as this could potentially 
be associated with disease initiation. Furthermore, we investigated the 
changes in the expression of complement factor C (C3), interleukin 
6 (IL6), chemokine C-X-C motif Ligand 2 (CXCL2), IL10, Tumour 
Necrosis Factor-α (TNF-α), Fas ligand, albumin and Intracellular 
Adhesion Molecule 1 (ICAM-1) in the liver, following nanomaterial 
exposure, to gain a better understanding how the organ responds, 
following a NM challenge.
Materials and Methods 
Nanomaterials were purchased as stated: NM 110 (ZnO-BASF 
Z-Cote; zinkite, uncoated, 100 nm), NM 111 (ZnO-BASF Z-Cote; 
zinkite coated with triethoxycaprylylsilane, 130 nm), NM 300 (Ag-
RAS GmbH; capped with polyoxylaurat Tween 20-<20 nm), NM 400 
(entangled MWCNT-Nanocyl; diameter 30 nm), NM 402 (entangled 
MWCNT-Arkema Graphistrength C100; diameter 30 nm). The above 
mentioned nanomaterials were sub-sampled under Good Laboratory 
Practice conditions and preserved under argon in the dark, until use. 
The TiO2 NRCWE samples were procured by the National Research 
Centre for the Working Environment. Sub-sampling was completed 
into 20 ml Scint-Burk glass pp-lock with Alu-Foil (WHEA986581; 
Wheaton Industries Inc.), after pooling. NRCWE 001, TiO2 rutile 10 
nm was purchased from NanoAmor (Houston, USA), and also used 
for production of NRCWE 002 (TiO2 rutile 10 nm with positive charge) 
[16]. Investigated nanomaterials were characterised by a combination 
of analytical techniques, in order to infer primary physical and chemical 
properties useful to understand their toxicological behaviour. A list of 
the measured physical and chemical properties of the selected NMs was 
previously described (Supplementary table 1) [16]. Furthermore, the 
hydrodynamic size distributions of the NMs dispersed in water with 
2% mouse serum was investigated at 1-128 µg/ml concentration range 
by Dynamic Light Scattering (DLS), using a Malvern Metasizer nano 
series–Nano ZS (USA) (Table 1).
Female C57/BL6 mice of 8 or 9 weeks were obtained from The 
University of Edinburgh (UK). After arrival, the animals were weighed 
and randomly housed in polypropylene cages, stored in rooms with a 
12 hr light period, with a temperature and relative humidity of 21 ± 2°C 
and 50 ± 5%, respectively. All mice were given free access to tap water 
and standard mouse chow diet. The animals were kept under specific 
pathogen free conditions.
Prior to injections, the NMs were dispersed in sterile water with 
2% mouse serum, according to the ENPRA protocol [17]. Mice were 
randomly assigned into cages in groups of 3, before being injected via 
the lateral tail vein, using a 27 gauge needle. All animals were kept 
under isoflurane anaesthesia, during the injection process (placed on 
a thermostat controlled heating device at 37°C). Animals were exposed 
to either a single dose of the different nanomaterials (128 µg/ml in 100 
µl), or three doses of 100 µl of 64 µg/ml, every 24 hr. A positive control 
of Lipopolysaccharide (LPS) (50 µl of 100 µg/ml) was also employed. 
The mice were dissected 6, 24, 48 and 72 hr after the single IV injection 
or 72 hr, after the triple injection regime (anaesthetised before being 
killed by cervical dislocation). The liver was then divided into four 
pieces. The middle lobe was divided into two–one half (about 0.2 g of 
tissue) was stored in RNAlater® (Life Technologies, UK). The left lobe 
was removed for MPO analysis (about 0.3 g of tissue). The right lobe 
was preserved in 10% formaldehyde for immunohistochemistry (about 
0.3 g of tissue). 
A mouse MPO ELISA kit (Hycult Biotech, USA) was utilised to 
quantify neutrophil influx into the liver tissue. Briefly, the tissue was 
lysed in a buffer consisting of 5 mM EDTA, 10 mM Tris, 10% glycerine, 
1 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin and 28 µg/ml 
aprotinin (pH 7.4). The samples were centrifuged twice at 1500 g for 
15 mins at 4°C to reduce contamination with cell debris. All samples 
were diluted 4 fold before being used in the ELISA kit, according to the 
manufacturer’s instructions.
The fixed tissue sections were transferred to embedding cassettes, 
before being dehydrated in 70% ethanol (2 changes, 1 hr each), 80% 
ethanol (2 changes, 1 hr each), 95% ethanol (2 changes, 1 hr each), 
100% ethanol (3 changes, 1 hr each) and Histoclear II (3 changes, 1 
hr each). The tissues were then embedded in paraffin wax (56-58°C-
2 changes, 1.5 hr each). The blocks were cut into thin slices (4 µm), 
before being transferred to a 45°C water bath. The paraffin sections 
were moved onto polysine glass slides, brushed into position, before 
being dried overnight at 37°C. The slides were rehydrated in Histoclear 
II (2 changes, 3 mins), Histoclear II 1:1 with 100% ethanol (3 mins), 
100% ethanol (2 changes, 3 mins), 95% ethanol (3 mins), 70% ethanol 
(3 mins), and 50% ethanol (3 mins). The sections were then washed 
in Tris Buffered Saline (TBS) plus 0.025% Triton X-100 (2×5 mins), 
and blocked 10% FCS in TBS for 2 hr at room temperature. The 
primary antibody diluted in TBS with 1% BSA (rat anti-mouse Ly-6B.2 
alloantigen-AbD Serotec, UK) was applied (100 µl per slide). The slides 
were incubated overnight at 4°C.
The slides were rinsed 2×5 mins in TBS plus 0.025% triton, and 
incubated in 0.3% H2O2 in TBS for 15 mins. The HRP conjugated 
secondary antibody was applied (human anti rat IgG2b: HRP–AbD 
Serotec, UK), before incubation at room temperature for 1 hr. The 
slides were rinsed 3×5 TBS and developed with 100 µl of DAB substrate 
kit (abcam, USA). The slides were washed and mounted with Mowiol 
4-88 (Polysciences Inc., UK). 
Liver samples were homogenised in liquid nitrogen, using a mortar 
NM code NM type Average size (suppliers information) Size in water with 2% serum (DLS) Ψ
NM 110 ZnO 100 nm 142.7 nm
NM 111 ZnO 130 nm 165.31 nm
NM 300 Ag <20 nm 42.94 nm
NM 400 MWCNT 30 nm 5 µm long NA
NM 402 MWCNT 30 nm 5 µm long NA
NRCWE 002 TiO2 10 nm 116.54 nm
Ψ Intensity based size average in biological media after 15 mins
Table 1: Average size of tested NMs as supplied by suppliers and as measured by DLS.
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and pestle. Homogenised tissues were stored at -80°C, before RNA was 
extracted and isolated using the MagMAXTM-96 Total RNA Isolation 
Kit (Ambion, USA). RNA concentration and purity were measured 
on a Nanodrop 2000c system (Thermo Scientific, UK). The High Ca-
pacity cDNA RT kit (Applied Biosystems, UK) was used according to 
the protocol, to transcribe RNA into cDNA. Equal quantities of RNA 
from 3 animals in the same treatment group were pooled and 300 ng 
of RNA were used in RT reactions. PCRs were conducted in triplicate 
on a 7900 RT fast PCR system and SDS 2.3 software in 384 well plates 
(Applied Biosystems, USA), using TaqMan kits, with FAM dye under 
standard TaqMan conditions for 50 cycles. The following Applied Bio-
systems kits were used: Mouse kits Mm00437762-m1–B2m (house-
keeping gene); Mm00436450-m1–CXCL2; Mm00439614-m1–IL10; 
Mm00443258-31–TNF-α; Mm00437858-m1–C3; Mm00438864-m1–
Fas ligand; Mm00516023-m1–ICAM-1; Mm00802090-m1–albumin 
and Mm00446190-m1–IL6.
All data are expressed as mean ± standard error of the mean. For 
statistical analysis, the experimental results were compared to their 
corresponding control values, using an ANOVA with Tukey’s multiple 
comparison. All statistical analysis was carried out utilizing Minitab 
15. A p value of <0.05 was considered to be significant. All experiments 
were repeated a minimum of three times.
Results and Discussion
This study was conducted as part of a large consortium (FP7 
funded project–ENPRA), to investigate the potential hazard of a wide 
range of nanomaterials on a variety of targets, in order to use the data 
for generation of a structure activity relationship and for modelling 
risk assessment. Several studies have demonstrated that NMs entering 
the body via the lungs, ingestion or direct injection accumulate in the 
liver [7-9]. In previous studies, it has been shown that hepatocytes are 
capable of producing potent neutrophil chemoattractants (human–
IL8 [15,16,18,19] rat-CINC-3) [20], following exposure to foreign 
matetrials, or in disease models. We therefore investigated neutrophil 
infiltration into the liver, following IV exposure of mice to a panel of 
engineered nanomaterials. Our previous studies have demonstrated 
that the panel of engineered nanomaterials investigated could be 
divided into a relatively high toxicity group and a lower toxicity group, 
according to their ability to induce cytotoxicity in the C3A cell line 
[16], primary human hepatocytes [19], primary rat co-cultures of 
hepatocytes and kupffer cells. Hence, six nanomaterials were chosen-
three of which were shown to be of higher toxicity (Ag and two ZnO 
NMs), and three that were of relatively low toxicity (positively charged 
TiO2 and two MWCNTs), in the in vitro systems. 
Myeloperoxidase is a lysosomal protein stored in granules of all 
granulocytes, and is found in largest quantities in neutrophils. In order 
to quantify PMN infiltration into the liver, we measured this enzyme in 
tissue samples. A modest but statistically significant increase in MPO 
in the liver, as early as 6 hr, following intravenous injection of the NMs 
was detected (Figure 1) (p<0.05). MPO content of the liver tissue had 
decreased to control levels by 48 hr, following exposure to Ag and TiO2 
(Figure 2). Multiple doses of Ag and TiO2 NMs did not enhance the 
MPO up-regulation further (Figure 3).
To confirm the increase in MPO in liver homogenates (Figure 1-3), 
and whether or not this was associated with the neutrophil influx, liver 
sections from exposed animals were stained using a specific neutrophil 
cell surface marker (Ly-6B.2). Staining demonstrated the presence 
of neutrophils in the tissues exposed to the positive control and the 
panel of nanomaterials, 6 hr post exposure, which were not evident 
Figure 1: MPO measured in the liver tissue following 6 hr exposure to 100 µl in 
128 µg/ml of the panel of NMs (NM 110–ZnO uncoated; NM 111–ZnO coated; 
NM 300–Ag; NM 400–MWCNT; NM 402-MWCNT; NRCWE 002–positively 
charged TiO2. A positive control of LPS (50 µl-100 µg/ml) was also employed. 
The negative control is representative of animals injected with 100 µl of PBS. 
(n=3 ± SEM) *P <0.05, **P<0.005 compared to negative control.
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Figure 2: MPO measured in the liver following 24, 48 and 72 hr exposure to 
100 µl of 128 µg/ml the NM 300–Ag and NRCWE 002–positively charged TiO2. 
A positive control of LPS (50 µl-100 µg/ml) was also employed. The negative 
control is representative of animals injected with 100 µl of PBS. (n=3 ± SEM) 
*P<0.05, **P<0.005 compared to negative control.
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Figure 3: MPO measured in the liver following 3 repeated doses of NMs over 
three days (3 doses of 100 µl of 64 µg/ml every 24 hr). The animals were 
dissected 72 hr following the initial dose. The negative control is representative 
of animals injected with three doses of 100 µl of PBS, while the positive control 
animals were injected with three doses of LPS (50 µl - 50 µg/ml per injection). 
(n=3±SEM) *P<0.05, **P<0.005compared to negative control.
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Figure 4: Ly6B.2 staining of mouse liver tissue by immunohistochemistry, 6 hr post intravenous exposure to ENPRA panel of engineered nanomaterials (100 µl-128 
µg/ml of NMs). A positive control of LPS (50 µl-100 µg/ml) was also employed. The negative control is representative of animals injected with 100 µl of PBS.
A) PBS B) LPS C) NM 110 D) NM 111 E) NM 300 F) NM 400 G) NM 402 H) NRCWE 002.
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in the negative control (Figure 4). Furthermore, the relative numbers 
of neutrophils stained in the tissues were comparable to the levels of 
MPO in liver in the time course experiments, showing that there was 
a decrease in neutrophil staining (Ag and TiO2) (Figure 5). Multiple 
dose of the silver and TiO2 also reflected the MPO results, showing that 
repeated exposures did not further enhance the neutrophil influx into 
the tissue (Figure 6).
Very low doses (12.8 µg of NMs per animal for single exposure or 
19.2 µg per animal for repeated exposure experiments) of NMs were 
injected into the mice in this study to represent a realistic exposure 
and to avoid toxicity to the animal. These doses are not dissimilar 
to other studies in which animals have been exposed to NMs via an 
IV route [21,22]. The findings in this study suggest that neutrophils 
are involved in the organs immunity to the foreign nanomaterials. 
To our knowledge, the role of neutrophils in the liver, following 
nanomaterial exposure has not been addressed previously, however, 
it has been shown that nautrophils can accumulate within hepatic 
microvasculature, following increase in inflammatory mediators such 
as TNF-α, IL1, MIP-2 and PAF [23,24]. Furthermore, in a recent study, 
an increase in numbers of neutrophils in the liver of BALB/c mice was 
observed during anaphylaxis [25]. 
In this study, it appears that the neutrophils are involved 
predominately in the initial phases of the immune response, on 
exposure to the NMs. The initial increase in neutrophil numbers in 
liver tissue was resolved by 48 hr post exposure. Neutrophils in other 
organs i.e. the lung are important part of the early innate immune 
response, as early as 4 hr post exposure to different antigen challenges 
[26,27], and can be involved in long term inflammation [28]. After 
the initial infiltration of the neutrophils into the tissue, the resident 
macrophages (Kupffer cells) may take over the immune response to 
the nanomaterials. It was also very interesting to note that repeated 
doses of the nanomaterials did not result in further accumulation of the 
polymorphonuclear leukocytes into the tissue, confirming our previous 
suggestion that neutrophils play no further part in the maintenance or 
the continuation of the inflammatory response. 
It has been shown that the most common neutrophil mediated 
Table 2: mRNA expression of inflammatory cytokines and receptors, FasL and albumin in C57/BL6 mice liver. The animals were exposed to 100 µl of 128 µg/ml of panel 
of nanomaterials for 6 hr by injection via the lateral tail vein. mRNA expression was analysed by  real time PCR with B2m utilised as an endogenous control.
Gene Expression NM 110 NM 111 NM 300 NM 400 NM 402 NRCWE 002
IL6 -200% -50% -200% 0 0 0
IL10 +75% 0 0 0 +50% +200%
C3 -50% -75% -75% -50% -75% 0
CXCL2 +200% 0 0 0 0 0
TNF-α 0 0 0 0 0 0
Fas ligand 0 0 0 0 0 0
ICAM-1 0 0 0 0 0 0
Albumin 0 0 0 0 0 0
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response in the liver is governed by the adhesion of the cells to 
hepatocytes (via ICAM-1 binding Mac-1) [24,29]. This adhesion 
triggers the formation of Reactive Oxygen Species (ROS) by NADPH 
oxidase, and release of proteases through the degranulation of the 
PMNs. This process could lead to neutrophilic hepatitis, characterised 
by self aggravating mechanisms, resulting in chronic disease [29]. This 
prolonged neutrophils response does not happen, following exposure 
to the nanomaterials utilised in this study. As already mentioned, the 
neutrophils decrease in number with time after the initial exposure. In 
addition, the up-regulation of ICAM-1 mRNA was only noted after 24 
hr and had returned to normal levels 48 hr post IV NM exposure. 
The expression of a range of genes related to inflammation, 
oxidative stress and apoptosis was analysed in the livers of mice 
exposed to the panel of engineered nanomaterials. Analysis of mRNA 
expression in mouse liver 6 hr after intravenous injection of 100 µl 
of 128 µg/ml of the panel of nanomaterials showed a decrease in C3 
following exposure to ZnO (NM 110 and NM 111), MWCNT (NM 
400 and NM 402) (Table 2). We noted a decrease in IL6 mRNA levels, 
following exposure to ZnO (NM 110, NM 111) and Ag NMs (NM 
300) (Table 1). An increase in IL10 was observed, following exposure 
to ZnO (NM 110) and TiO2 (NRCWE 002) (Table 1). Finally, a large 
increase in CXCL2 was demonstrated, following exposure to ZnO. No 
significant changes were detected in the expression of albumin, TNF-α, 
albumin, Fas ligand or ICAM-1, following treatment with any of the 
nanomaterials (Table 2).
Repeated exposure of the C57/BL6 mice to three doses of the Ag 
(NM 300) and positively charged TiO2 (NRCWE 002) nanomaterials 
resulted in a large increase in IL10 levels, while smaller yet significant 
decreases in C3 and ICAM-1 mRNA were noted, following exposure to 
both NMs (Ag and TiO2) (Table 3).
Finally, the animals were exposed to a single dose of 100 µl of 64 
µg/ml of the Ag and positively charged TiO2 NMs by injection via 
the lateral tail vein. The animals were dissected 24 hr, 48 hr and 72 hr 
after the initial injection. We found that in all instances, the increase 
or decrease in mRNA was most evident after the 24 hr exposure. For 
all the genes investigated in this study, resolution to control levels had 
occurred 72 hr post exposure (Tables 4 and 5). 
Complement factor 3 is one of the most abundant and important 
proteins in the complement cascade. C3 activation is essential for all 
the functions of the complement system. It is crucial in promoting 
phagocytosis, supporting the local immune response against foreign 
Figure 5: Ly6B.2 staining of mouse liver tissue by immunohistochemistry 
representing samples from animals 24, 48 or 72 hr post intravenous exposure 
to ENPRA panel of engineered nanomaterials (100 µl-128 µg/ml of NMs). 
A) NM 300–24 hr B) NRCWE 002–24 hr C) NM 300–48 hr D) NRCWE 002–
48 hr E) NM 300–72 hr F) NRCWE 002–72 hr.
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Figure 6: Ly6B.2 staining of mouse liver tissue by immunohistochemistry 
following three repeated doses over three days (3 doses of 100 µl of 64 µg/
ml of NMs every 24 hr). The animals were dissected 72 hr, following the 
initial dose. 
A) NM 300 B) NRCWE 002.
 
 
A 
B 
Gene Expression NM 300 NRCWE 002
IL6 0 0
IL10 +200% +200%
C3 -100% -100%
CXCL2 0 0
TNF-α +50% 0
Fas Ligand 0 0
ICAM-1 -100% -100%
Albumin 0 0
Table 3: mRNA expression of inflammatory cytokines and receptors, FasL and 
albumin in C57/BL6 mice liver. The animals were exposed three times (0 hr, 24 hr 
and 48 hr ) to 100 µl of 64 µg/ml of the Ag (NM 300) and the positively charged TiO2 
NMs by injection via the lateral tail vein. The animals were dissected 72 hr after the 
first injection and the mRNA expression was analysed by real time PCR, with B2m 
utilised as an endogenous control.
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agents, and instructing the adaptive immune responses to select the 
appropriate antigens for any eventual antibody response [30]. Moreover, 
C3 might be capable of interaction with the coagulation system and 
contributing to pro-coagulation, and ultimately, a prothrombotic state 
[31]. The decrease in C3 expression might suggest that exposure to 
low doses of NMs in this study results in overall tolerance in the liver, 
rather than a fully developed immune response. 
There was a decrease in IL6 mRNA levels, following exposure to the 
ZnO and Ag NMs, after 6 hr exposure. IL6 is a multifunctional cytokine 
that acts on a number of cell types, including B and T lymphocytes, 
hepatocytes, hematopoietic progenitor cells and neuronal cells [32]. 
Under different circumstances, the cytokine can be both pro- and 
anti-inflammatory. In the liver, IL6 is a potent inducer of acute phase 
proteins, which are in most part pro-inflammatory proteins (including 
C reactive protein, complement factors and serum amyloid A) [33]. 
Once again, the decrease in IL6 expression advocates that exposure to 
low doses of these NMs results in tolerance in the liver.
IL10 is a multifunctional cytokine with diverse effects on a wide 
range of hemopoietic cells. The cytokine’s principle function is to 
terminate inflammatory responses [34]. IL10 also regulates growth 
or differentiation of B and T lymphocytes, NK cells, mast cells, most 
granulocytes, dendritic cells, keratinocytes, and endothelial cells 
[35]. IL10 also plays a key role in differentiation of regulatory T cells, 
which figure prominently and importantly in the control of immune 
responses, and developing a tolerant immune state [35]. Analysis of 
IL10 mRNA showed an increase, following exposure to exposure to 
NM 110 (uncoated ZnO), NM 300 (Ag), NM 402 (MWCNT) and 
NRCWE 002 (TiO2). The increase in IL10 mRNA was the largest and 
the most significant of all the genes investigated in this study, once 
again suggesting tolerance as being the overall response in the organ, 
following acute low exposure to NMs.
CXCL2 also known as Macrophage Inflammatory Protein 2 
alpha (MIP-2) is a chemokine secreted from a number of cell types, 
in particular, monocytes and macrophages [36]. CXCL2 is a potent 
chemoattractant for neutrophils and hematopoetic stem cells [36]. A 
large increase in CXCL2 was observed following exposure to NM 110 
(uncoated ZnO), following 6 hr exposure. It is important to note that 
increases compared to base levels of CXCL2 were also demonstrated 
following the 6 hr exposure to other nanomaterials, however, due 
to large fluctuations in the control group of animals, these changes 
could not be regarded as significant. Up-regulation of CXCL2 could 
be associated with the short term acute recruitment of PMNs into the 
liver.
No significant changes were detected in the expression of albumin, 
TNF-α, Fas ligand or ICAM-1, following 6 hr exposure to any of the 
nanomaterials utilised in this study. The fact that there was no change 
in the levels of TNF-α would again suggest that there is no significant 
pro-inflammatory response, following exposure to the NMs. FasL (also 
referred to as CD95L) is a homotrimeric type II transmembrane protein 
signalling through trimerisation with CD95 on the target cells, leading 
to death by apoptosis [37]. The findings here would suggest that there 
is no apoptosis, following exposure to these particular nanomaterials at 
the time points used here, however, it is possible that FasL may be up-
regulated at later time points, in relation to the clearance of PMN from 
the liver. There was no change in albumin gene expression suggesting 
that the NM challenge at these low doses does not affect liver function.
Repeated exposure of the mice to three doses of the Ag (NM 300) 
and positively charged (NRCWE 002) nanomaterials again resulted in 
large increases in IL10 levels, while smaller yet significant decreases in 
C3 and ICAM-1 mRNA were noted, following exposure to both NMs. 
ICAM-1 (Intracellular Adhesion Molecule 1) is a molecule involved 
in attraction and adhesion of inflammatory cells to endothelial and 
epithelial cells, and its soluble form, sICAM-1, is linked to activation 
of these cells in pathological responses [38]. It is up-regulated in liver 
associated diseases, such as in hepatitis C [38]. As already mentioned, 
binding of ICAM-1 to Mac-1 on hepatocytes is crucial to neutrophil 
mediated response in the liver. The overall decrease in ICAM-1 mRNA 
suggests that neutrophils are not involved at the latter stages of the liver 
immunity, despite fresh foreign nanomaterial challenges. 
Finally, a group of animals were exposed to a single dose of 100 µl of 
64 µg/ml of the Ag and positively charged TiO2 NMs. The animals were 
dissected 24 hr, 48 hr and 72 hr after the initial injection. We found 
that in all instances, the greatest changes in mRNA occurred after the 
24 hr exposure. These changes resolved and all the genes investigated 
returned to background levels, after 72 hr post exposure. 
It is important to emphasize the limitations of this study. It may be 
important to examine earlier time points to gain a better understanding 
of the role of neutrophils in the liver, following a NM challenge. Future 
studies may include the utilisation of microarray analysis for a more 
comprehensive gene expression profile in the liver. Any potential 
changes in a large number of genes, including those of the cytochrome 
P450 family, heat shock proteins and IL1 family of proteins could be 
important indicators of NM impact on the liver. Furthermore, it might 
be important to examine presence of neutrophils in blood and compare 
with liver tissue. It is possible that these cells are also responsible for 
initiating the reparative process that is later managed by macrophages. 
Overall, the findings in this study suggest that intravenous exposure 
Table 4: mRNA expression of inflammatory cytokines and receptors, FasL and 
albumin in C57/BL6 mice liver. The animals were exposed to a single dose of 
100 µl of 128 µg/ml of the Ag NM (NM 300), by injection via the lateral tail vein. 
The animals were dissected 24 hr, 48 hr and 72 hr after the initial injection and 
the mRNA expression was analysed by real time PCR with B2m utilised as an 
endogenous control. 
Gene Expression (NM 300) Day 1 Day 2 Day 3
C3 -75% -50% 0
IL6 +100% +100% 0
IL10 +200% +75% 0
CXCL2 0 0 0
TNF-α 0 0 0
Fas Ligand +75% 0 0
ICAM-1 +75% 0 0
Albumin 0 0 0
Table 5: mRNA expression of inflammatory cytokines and receptors, FasL and 
albumin in C57/BL6 mice liver. The animals were exposed to a single dose of 100 
µl of 128 µg/ml of the TiO2 NM (NRCWE 002) by injection via the lateral tail vein. 
The animals were dissected 24 hr, 48 hr and 72 hr after the initial injection and 
the mRNA expression was analysed by real time PCR, with B2m utilised as an 
endogenous control. 
Gene Expression (NRCWE 002) Day 1 Day 2 Day 3
C3 -75% 0 0
IL6 0 0 0
IL10 +200% +200% 0
CXCL2 0 0 0
TNF-α 0 0 0
Fas Ligand +75% 0 0
ICAM-1 +75% 0 0
Albumin 0 0 0
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of mice to the ENPRA panel of engineered nanomaterials results in 
neutrophil governed acute effects in the liver. The low doses used were 
not sufficient to cause any longer term inflammation in the liver tissue. 
Any changes that were observed after 24 hr post exposure, in terms 
of leukocyte infiltration and changes in gene expression related to 
inflammation, oxidative stress and apoptosis had resolved 72 hr post 
exposure.
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